Performance of the Models Predicting In-Hospital Mortality in Patients with ST-Segment Elevation Myocardial

K I Shakhgeldyan1, N S Kuksin2, I G Domzhalov3

  • 1Associate Professor, Director of the Institute of Information Technologies; Vladivostok State University, 41 Gogolya St., Vladivostok, 690014, Russia; Head of the Laboratory of Big Data Analysis in Medicine and Healthcare; Far East Federal University, 10 Ayaks Village, Russkiy Island, Vladivostok, 690922, Russia.

PubMed

Insights

Predictive models for in-hospital mortality in ST-segment elevation myocardial infarction patients after percutaneous coronary intervention were developed. Machine learning models showed high accuracy, with Shapley additive explanations aiding predictor analysis.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Data Science

Background:

  • Predicting in-hospital mortality (IHM) in ST-segment elevation myocardial infarction (STEMI) patients post-percutaneous coronary intervention (PCI) is crucial for patient management.
  • Existing scoring systems may not fully capture the complexity of IHM prediction in this population.
  • The study investigates the utility of continuous and categorical predictors in enhancing IHM prediction models.

Purpose of the Study:

  • To assess the performance of predictive models for IHM in STEMI patients undergoing PCI.
  • To compare models developed using continuous versus categorical predictor forms.
  • To identify novel predictors and evaluate their influence on IHM using advanced analytical methods.

Main Methods:

  • Retrospective analysis of 4674 patient records from a single center.
  • Development of IHM prognostic models using multivariate logistic regression (MLR), random forest (RF), and stochastic gradient boosting (SGB).
  • Application of Shapley additive explanations (SHAP) for predictor categorization and influence assessment.

Main Results:

  • New IHM predictors were identified and validated, augmenting the GRACE scoring system factors.
  • Developed MLR, RF, and SGB models demonstrated high and comparable predictive accuracy (AUC 0.88-0.90).
  • SHAP analysis revealed varying predictor influences and offered advantages in categorizing predictors compared to other methods.

Conclusions:

  • Machine learning algorithms and SHAP analysis enable the development of accurate and interpretable predictive models for IHM.
  • Categorization of predictors and assessment of their impact enhance model transparency and clinical utility.
  • These advanced data mining techniques offer a robust approach to improving prognostic accuracy in STEMI patients.

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
156
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
99
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
103
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
68
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
2